Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
- PMID: 15166541
- DOI: 10.1097/00002030-200405210-00019
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
Abstract
The seroprevalence of adenovirus types 5 (Ad5) and 35 (Ad35) was investigated in patients at risk of AIDS. The seroprevalence of Ad5 was higher than Ad35 in HIV-infected patients from The Netherlands (60% versus 7%) and sub-Saharan Africa (90% versus 20%). The seroprevalence was similar among HIV-infected and uninfected individuals, and remained constant during progression to AIDS. Ad35 is less prone to neutralization than Ad5, encouraging the further development of Ad35 for vaccination against HIV.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical